De Chao Yu

De Chao Yu

Chief Executive Officer at INNOVENT BIOLOGICS, INC.

Net worth: 1 264 M $ as of 30/04/2026

62 year
Health Technology
Commercial Services
Consumer Services

Profile

Founder of Innovent Biologics, Inc. and Chengdu Kanghong Pharmaceutical Group Co., Ltd., De Chao Yu occupies the position of Chairman & Chief Executive Officer at Innovent Biologics, Inc. and Chairman for Chinese Antibody Society. He is also on the board of Babytree Group and Cheerwin Group Ltd. and Professor at Sichuan University. De Chao Yu previously was President & Chief Executive Officer at Chengdu Kanghong Pharmaceutical Group Co., Ltd., Vice President-Research & Development of Applied Genetic Technologies Corp., Vice President-Research & Development at Applied Genetics, Inc., President & Chief Executive Officer for Kanghong Sagent Chengdu Pharmaceutical Corp. Ltd., Vice President-Research & Development for Calyon North America, Inc., Vice President at Calydon, Inc. and Managing Director at China Medicinal Biotech Association. He received a doctorate from Chinese Academy of Sciences.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
11/05/2026 11,00,58,657 ( 6.34% ) 1 264 M $ 30/04/2026

De Chao Yu active positions

CompaniesPositionStart
INNOVENT BIOLOGICS, INC. Chief Executive Officer 28/04/2011
DIAN DIAGNOSTICS GROUP CO.,LTD. Director/Board Member 03/11/2023
Corporate Officer/Principal 01/01/2008
Chairman 01/01/2017

Former positions of De Chao Yu

CompaniesPositionEnd
BABYTREE GROUP Director/Board Member 10/05/2023
CHEERWIN GROUP LIMITED Director/Board Member 14/10/2022
China Medicinal Biotech Association
Corporate Officer/Principal 01/01/2019
PHARMABLOCK SCIENCES (NANJING), INC. Director/Board Member 01/01/2018
CHENGDU KANGHONG PHARMACEUTICAL GROUP CO., LTD Chief Executive Officer 01/01/2011
See the detail of De Chao Yu's experience

Training of De Chao Yu

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

66

1st degree connections

15

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies15

Health Technology

Health Technology

Consumer Services

Consumer Services

Finance

Health Technology

China Medicinal Biotech Association

Health Services

Health Technology

Health Technology

Commercial Services

Commercial Services

Commercial Services

Process Industries